James C. Metcalfe
#138,859
Most Influential Person Now
James C. Metcalfe's AcademicInfluence.com Rankings
James C. Metcalfebiology Degrees
Biology
#9703
World Rank
#12939
Historical Rank
Cell Biology
#427
World Rank
#437
Historical Rank
Genetics
#997
World Rank
#1094
Historical Rank
Molecular Biology
#1349
World Rank
#1376
Historical Rank
Download Badge
Biology
James C. Metcalfe's Degrees
- PhD Molecular Biology Stanford University
- Masters Biochemistry University of California, San Francisco
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is James C. Metcalfe Influential?
(Suggest an Edit or Addition)James C. Metcalfe's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genetic control of the circulating concentration of transforming growth factor type beta1. (1999) (774)
- High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. (1994) (664)
- The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis (1995) (416)
- Proliferation of human smooth muscle cells promoted by lipoprotein(a). (1993) (391)
- Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. (1993) (391)
- Free cytoplasmic calcium concentration and the mitogenic stimulation of lymphocytes. (1983) (386)
- A common sequence of calcium and pH signals in the mitogenic stimulation of eukaryotic cells (1985) (382)
- Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice (1994) (381)
- Cholesterol is excluded from the phospholipid annulus surrounding an active calcium transport protein (1975) (347)
- Reconstitution of a calcium pump using defined membrane components. (1974) (320)
- The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. (1984) (315)
- A Transforming Growth Factorβ1 Signal Peptide Variant Increases Secretion in Vitro and Is Associated with Increased Incidence of Invasive Breast Cancer (2003) (303)
- Biological responses to electromagnetic fields 1 (1998) (290)
- Annular lipids determine the ATPase activity of a calcium transport protein complexed with dipalmitoyllecithin. (1976) (281)
- Reversible lipid titrations of the activity of pure adenosine triphosphatase-lipid complexes. (1974) (250)
- Clusters in lipid bilayers and the interpretation of thermal effects in biological membranes. (1974) (235)
- 13 C nuclear magnetic resonance relaxation measurements of synthetic lecithins and the effect of spin-labeled lipids. (1972) (224)
- Release and activation of platelet latent TGF–β in blood clots during dissolution with plasmin (1995) (214)
- Degenerate perturbations of protein structure as the mechanism of anaesthetic action (1978) (188)
- TGF-β in blood: a complex problem (2000) (178)
- The calcium signal and phosphatidylinositol breakdown in 2H3 cells. (1984) (177)
- Proton NMR analysis of plasma is a weak predictor of coronary artery disease (2006) (175)
- Intracellular calcium measurements by 19F NMR of fluorine-labeled chelators. (1983) (175)
- Mechanisms of pHi recovery after global ischemia in the perfused heart. (1993) (173)
- Mitogens increase phosphorylation of phosphoinositides in thymocytes (1984) (168)
- The effect of bilayer thickness and n-alkanes on the activity of the (Ca2+ + Mg2+)-dependent ATPase of sarcoplasmic reticulum. (1981) (152)
- The effect of bilayer thickness on the activity of (Na+ + K+)-ATPase. (1981) (149)
- The interaction of small molecules with spin-labelled erythrocyte membranes. (1970) (146)
- High resolution proton relaxation studies of lecithins. (1972) (145)
- A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. (2003) (143)
- Tamoxifen elevates transforming growth factor–β and suppresses diet–induced formation of lipid lesions in mouse aorta (1995) (140)
- The proton relaxation of benzyl alcohol in erythrocyte membranes. (1968) (136)
- The localisation of small molecules in lipid bilayers (1972) (133)
- Transforming growth factor-β1 gene polymorphisms and coronary artery disease (1998) (128)
- 13C NMR Spectra of Lecithin Vesicles and Erythrocyte Membranes (1971) (124)
- Measurement of fast lateral diffusion of lipids in vesicles and in biological membranes by 1 H nuclear magnetic resonance. (1973) (124)
- Tamoxifen: Teaching an old drug new tricks? (1996) (124)
- The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. (1990) (123)
- Calculation of dipolar nuclear magnetic relaxation times in molecules with multiple internal rotations. II. Theoretical results for anisotropic over‐all motion of the molecule, and comparison with 13C relaxation times in n ‐alkanes and n ‐alkyl bromides (1974) (119)
- The lipid environment of the glucagon receptor regulates adenylate cyclase activity. (1976) (118)
- The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it. (1976) (114)
- Dipalmitoyl-lecithin: assignment of the 1H and 13C nuclear magnetic resonance spectra, and conformational studies (1972) (110)
- Is an early calcium flux necessary to stimulate lymphocytes? (1977) (109)
- Transforming growth factor-beta dynamically regulates vascular smooth muscle differentiation in vivo. (1998) (100)
- Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice. (1997) (99)
- Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions. (2000) (97)
- No effect of 60 Hz electromagnetic fields on MYC or beta-actin expression in human leukemic cells. (1995) (95)
- Free cytosolic Ca2+ measurements with fluorine labelled indicators using 19FNMR. (1985) (92)
- Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase. (1994) (88)
- c-fos and c-myc gene activation, ionic signals, and DNA synthesis in thymocytes. (1986) (85)
- Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer. (2001) (85)
- Active and acid-activatable TGF-β in human sera, platelets and plasma (1995) (82)
- Calcium and cell proliferation. (1986) (80)
- Synergistic signals in the mechanism of antigen-induced exocytosis in 2H3 cells: evidence for an unidentified signal required for histamine release (1987) (79)
- The interaction of paramagnetic ions and spin labels with lecithin bilayers. (1973) (78)
- 13C Nuclear magnetic relaxation times and models for chain motion in lecithin vesicles (1972) (78)
- Tamoxifen Effects on Endothelial Function and Cardiovascular Risk Factors in Men With Advanced Atherosclerosis (2001) (77)
- Biological responses to electromagnetic fields (1998) (76)
- 13 C and 1 H nuclear magnetic resonance relaxation measurements of the lipids of sarcoplasmic reticulum membranes. (1972) (76)
- Exchange of partners in glucagon receptor-adenylate cyclase complexes. Physical evidence for the independent, mobile receptor model. (1977) (74)
- TGF-beta in blood: a complex problem. (2000) (72)
- Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions. (1999) (70)
- Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. (2000) (69)
- A calcium hypothesis for the control of cell growth. (1980) (68)
- Some mitogens cause rapid increases in free calcium in fibroblasts (1984) (67)
- Intracellular pH of stimulated thymocytes measured with a new fluorescent indicator. (1983) (65)
- Ca2+ transient, Mg2+, and pH measurements in the cardiac cycle by 19F NMR. (1988) (64)
- Regulation of intracellular pH in the perfused heart by external HCO3- and Na(+)-H+ exchange. (1993) (64)
- Four isoforms of serum response factor that increase or inhibit smooth-muscle-specific promoter activity. (2000) (64)
- Complete control of the lipid environment of membrane‐bound proteins: Application to a calcium transport system (1974) (60)
- Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. (1998) (58)
- 13C NMR spectra of acholeplasma membranes containing13C labelled phospholipids (1972) (57)
- Increased PAI activity and PAI-1 antigen occurring with an oral fat load: associations with PAI-1 genotype and plasma active TGF-beta levels. (1998) (56)
- Feedback Mechanism of Focal Vascular Lesion Formation in Transgenic Apolipoprotein(a) Mice* (1996) (55)
- The exogenous lipid requirement for histamine release from rat peritoneal mast cells stimulated by concanavalin A (1979) (55)
- Limitations on the use of phenothiazines and local anaesthetics as indicators of calmodulin function in intact cells (1982) (53)
- Relaxation of Anaesthetics in the Presence of Cyto-membranes (1968) (52)
- Intracellular pH and free calcium changes in single cells using quene 1 and quin 2 probes and fluorescence microscopy (1983) (52)
- A PIVOTAL ROLE FOR TGF‐β* IN ATHEROGENESIS? (1995) (52)
- TGF-β Signaling Pathway and Breast Cancer Susceptibility (2011) (51)
- Ca2+ and pH responses to sequential additions of mitogens in single 3T3 fibroblasts: correlations with DNA synthesis. (1988) (51)
- Optimization of immunofluorescence methods by quantitative image analysis. (1996) (50)
- The phospholipid headgroup specificity of an ATP-dependent calcium pump. (1978) (49)
- Adult human aortic smooth muscle cells in culture produce active TGF-beta. (1993) (49)
- Tamoxifen decreases the rate of proliferation of rat vascular smooth-muscle cells in culture by inducing production of transforming growth factor beta. (1993) (48)
- The binding of benzyl alcohol to erythrocyte membranes. (1970) (48)
- Inhibition of proliferative retinopathy by the anti-vascular agent combretastatin-A4. (2002) (45)
- Lipid phase transitions control β‐hydroxybutyrate dehydrogenase activity in defined‐lipid protein complexes (1975) (44)
- Design of an indicator of intracellular free Na+ concentration using 19F-NMR. (1986) (44)
- Approaches to the development of selective inhibitors of vascular smooth muscle cell proliferation. (1993) (44)
- A determination of the mobility gradient in lipid bilayers by 13C nuclear magnetic resonance (1976) (43)
- Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGF beta. (1995) (43)
- Splenomegaly and Modified Erythropoiesis in KLF13–/– Mice* (2008) (41)
- Cloning and analysis of the promoter region of the rat SM22α gene (1995) (41)
- Increased actin polymerization reduces the inhibition of serum response factor activity by Yin Yang 1. (2002) (40)
- Changes in free-calcium levels and pH in synaptosomes during transmitter release. (1984) (40)
- Nuclear Magnetic Relaxation and the Biological Membrane (1974) (39)
- Cholesterol in sarcoplasmic reticulum and the physiological significance of membrane fluidity. (1981) (39)
- Design and properties of a fluorescent indicator of intracellular free Na+ concentration. (1988) (38)
- Intracellular pH recovery during respiratory acidosis in perfused hearts. (1994) (37)
- Calcium signals and phospholipid methylation in eukaryotic cells. (1984) (37)
- Transient complexes. A new structural model for the activation of adenylate cyclase by hormone receptors (guanine nucleotides/irradiation inactivation). (1979) (37)
- A large accumulation of non-muscle myosin occurs at first entry into M phase in rat vascular smooth-muscle cells. (1991) (37)
- cis-Unsaturated fatty acids uncouple mitochondria and stimulate glycolysis in intact lymphocytes. (1984) (37)
- Mitogens for adult rat aortic vascular smooth muscle cells in serum-free primary culture. (1994) (36)
- Expression of Klf9 and Klf13 in mouse development (2001) (36)
- Calcium regulates inositol 1,3,4,5‐tetrakisphosphate production in lysed thymocytes and in intact cells stimulated with concanavalin A. (1987) (36)
- Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum. (1993) (35)
- Mouse BTEB3, a new member of the basic transcription element binding protein (BTEB) family, activates expression from GC-rich minimal promoter regions. (2000) (35)
- Loss of a consensus heparin binding site by alternative splicing of latent transforming growth factor‐β binding protein‐1 (1998) (35)
- Carbonic anhydrase and cardiac pH regulation. (1996) (35)
- 19 F NMR of monofluorostearic acids in lecithin vesicles. (1971) (33)
- Triggering of lymphocyte capping appears not to require changes in potential or ion fluxes across the plasma membrane. (1980) (32)
- Adhesion of Endothelial Cells to NOV Is Mediated by the Integrins αvβ3 and α5β1 (2003) (31)
- Duration of the calcium signal in the mitogenic stimulation of thymocytes. (1983) (30)
- KLF13 influences multiple stages of both B and T cell development (2008) (30)
- Early increases in phospholipid methylation are not necessary for the mitogenic stimulation of lymphocytes. (1982) (30)
- Active and acid-activatable TGF-beta in human sera, platelets and plasma. (1995) (30)
- Early Response Pattern Analysis of the Mitogenic Pathway in Lymphocytes and Fibroblasts (1985) (29)
- Angiotensin II stimulates sodium-dependent proton extrusion in perfused ferret heart. (1996) (28)
- Cap formation by various ligands on lymphocytes shows the same dependence on high cellular ATP levels. (1980) (28)
- Transforming growth factor-beta and the protection from cardiovascular injury hypothesis. (1995) (27)
- Structural comparisons of native and reaggregated membranes from Mycoplasma laidawii and erythrocytes using a fluorescence probe. (1971) (26)
- The Id gene is activated by serum but is not required for de-differentiation in rat vascular smooth muscle cells. (1991) (26)
- Transforming growth factor-b1 gene polymorphisms and coronary artery disease (1998) (25)
- Structural comparisons of native and reaggregated membranes from Mycoplasma laidlawii and erythrocytes by x-ray diffraction and nuclear magnetic resonance techniques. (1971) (25)
- Expression of alternatively spliced human latent transforming growth factor β binding protein‐1 (1998) (25)
- Transforming growth factor-beta: the key to understanding lipoprotein(a)? (1995) (25)
- Estimation of systolic and diastolic free intracellular Ca2+ by titration of Ca2+ buffering in the ferret heart. (2000) (24)
- Transforming growth factor beta is sequestered into an inactive pool by lipoproteins. (1997) (24)
- Microsatellite Mutation of Type II Transforming Growth Factor-&bgr; Receptor Is Rare in Atherosclerotic Plaques (2001) (24)
- A pivotal role for TGF-beta in atherogenesis? (1995) (22)
- Adhesion of endothelial cells to NOV is mediated by the integrins alphavbeta3 and alpha5beta1. (2003) (22)
- Investigation of a hapten-antibody complex by nuclear magnetic resonance. (1967) (21)
- Cancer risk and electromagnetic fields (1995) (20)
- Cloning and analysis of the promoter region of the rat SM22 alpha gene. (1995) (19)
- Cultures of proliferating vascular smooth muscle cells from adult human aorta. (1996) (18)
- A Common Phenotype Associated with Atherogenesis in Diverse Mouse Models of Vascular Lipid Lesions (2001) (17)
- NMR STUDIES OF LIPIDS IN BILAYERS AND MEMBRANES (1973) (17)
- Gene Expression Profiles in White Blood Cells of Volunteers Exposed to a 50 Hz Electromagnetic Field (2012) (17)
- Physico-chemical studies on gelatin gels from soluble and insoluble collagens (1967) (17)
- The design and properties of a series of calcium indicators which shift from rhodamine-like to fluorescein-like fluorescence on binding calcium (1993) (16)
- Mitogenic stimulation and the redistribution of concanavalin A receptors on lymphocytes. (1981) (16)
- Hexamethylenebisacetamide selectively inhibits the proliferation of human and rat vascular smooth-muscle cells. (1992) (16)
- The application of nuclear magnetic resonance to pharmacological problems * (1970) (15)
- Analysis of the 13C T1 relaxation times in n-alkanes (1973) (15)
- Ca2+ buffering in the heart: Ca2+ binding to and activation of cardiac myofibrils. (2000) (15)
- Selective modulation of the SM22alpha promoter by the binding of BTEB3 (basal transcription element-binding protein 3) to TGGG repeats. (2003) (14)
- Kinetic evidence for a common mechanism of capping on lymphocytes. (1982) (14)
- Mg2+ regulates the ATPase activity of a calcium transport protein by interacting with bound phosphatidic acid (1975) (14)
- 13C-enriched phosphatidylethanolamines from Escherichia coli. (1975) (13)
- Magnetic resonance studies of anaesthetics in cyto-membranes. (1969) (12)
- TGF-beta: implications for human vascular disease. (1995) (12)
- 13 C NMR studies of lipids in bilayers and membranes. (1972) (12)
- Calcium measurements with a new high-affinity n.m.r. indicator in the isolated perfused heart. (1993) (12)
- Synthesis and tritium radiolabelling of fluorinated analogues of myo-inositol (1992) (12)
- Large effects of preparative techniques on lymphocyte cyclic AMP content. (1983) (10)
- Limits to the early increase in free cytoplasmic calcium concentration during the mitogenic stimulation of lymphocytes. (1983) (10)
- Phosphoinositide metabolism and the calcium response to concanavalin A in S49 T-lymphoma cells. A comparison with thymocytes. (1988) (10)
- Biochemistry of cell walls and membranes II (1978) (9)
- Resting and end‐diastolic [Ca2+]i measurements in the langendorff‐perfused ferret heart loaded with a 19F NMR indicator (1993) (9)
- Permeabilization of thymocytes by photon activation of erythrosin (1987) (9)
- The uptake of 3H-labelled monodeoxyfluoro-myo-inositols into thymocytes and their incorporation into phospholipid in permeabilized cells. (1993) (9)
- What is the phospholipid specificity of a reconstituted calcium pump? (1977) (9)
- Effects of fluorinated inositols on the proliferation of Swiss 3T3 fibroblasts. (1993) (8)
- Angiotensin II Stimulates Acid Extrusion in Heart (1993) (8)
- Interaction of Local Anaesthetics and Calcium with Erythrocyte Membranes (1970) (8)
- The specificity of drug receptors. An immunochemical model for cholinergic receptors. (1969) (8)
- TGF-b Signaling Pathway and Breast Cancer Susceptibility (2011) (7)
- Synthesis of some deoxy-fluoro analogues of myo-inositol (1990) (7)
- The interaction of fluorescence and nuclear magnetic resonance probes with erythrocyte membrane protein fractions. (1972) (7)
- Localization of latent transforming growth factor-β binding protein-1 in human coronary atherosclerotic plaques. (2011) (6)
- ID ‐ A dominant negative regulator of skeletal muscle differentiation — is not involved in maturation or differentiation of vascular smooth muscle cells (1995) (6)
- Immuno-adsorbents of High Capacity (1966) (6)
- 15 – Intracellular Calcium and Normal Eukaryotic Cell Growth (1987) (6)
- A new 19F NMR indicator for intracellular sodium (1993) (6)
- Transforming growth factor-beta1 inhibits thrombin activation of endothelial cells. (2004) (5)
- Design and properties of new 19F NMR Ca2+ indicators: modulation of the affinities of BAPTA derivatives via alkylation (1993) (5)
- Mechanisms of intracellular pH recovery following global ischaemia in the perfused ferret heart (1992) (5)
- The value of proton relaxation measurements in the study of aqueous phospholipid dispersions (1971) (5)
- A common requirement for p21c-ras function in the mitogenic signaling pathways of Swiss 3T3 fibroblasts. (1993) (5)
- On the Mechanism of Binding Choline Derivatives to an Anticholine Antibody (1968) (5)
- THE LATERAL ORGANISATION OF LIPIDS AROUND A CALCIUM TRANSPORT PROTEIN: EVIDENCE FOR A PHOSPHOLIPID ANNULUS THAT MODULATES FUNCTION (1976) (5)
- TGFβ/activin signaling pathway activation in intimal hyperplasia and atherosclerosis. (2011) (5)
- CALCIUM AND LYMPHOCYTE ACTIVATION (1982) (5)
- The structural features determining the affinity of haptens for an antibody binding acetylcholine. (1969) (4)
- C‐fos gene activation in murine thymocytes by a mechanism independent of protein kinase C or a Ca2+ signal (1988) (4)
- Transforming growth factor-beta gene polymorphisms and coronary artery disease (1998) (4)
- The Molecular Architecture of a Reconstituted Calcium Pump (1977) (4)
- Sedimentation Studies of Gelatin Gels (1963) (4)
- Mitogen-stimulated activation of the Na+/H+ antiporter does not regulate S6 phosphorylation or protein synthesis in murine thymocytes or Swiss 3T3 fibroblasts. (1990) (4)
- The bivalent-cation dependence of phosphatidylinositol synthesis in a cell-free system from lymphocytes. (1983) (4)
- Magnetic Resonance Studies of Membranes and Lipids (1971) (3)
- 14 – Nuclear Magnetic Resonance Spectroscopy (1970) (3)
- GTPγS activation of proto‐oncogene expression in transiently permeabilised Swiss 3T3 fibroblasts (1988) (2)
- Inhibition of PDGF BB stimulated DNA synthesis in rat aortic vascular smooth muscle cells by the expression of a truncated PDGFβ receptor (1993) (2)
- GTPγS inhibits early c‐myc protein accumulation but not DNA synthesis in Swiss 3T3 fibroblasts (1990) (2)
- Heparin Partially Inhibits Proliferation of Vascular Smooth Muscle Cells (VSMC) by Extending the G2 Phase of the Cell Cycle (1991) (2)
- Erratum: Proton NMR analysis of plasma is a weak predictor of coronary artery disease (2006) (2)
- ACTIVATION OF TRANSFORMING GROWTH-FACTOR-BETA IS INVERSELY CORRELATED WITH 3 MAJOR RISK-FACTORS FOR CORONARY-ARTERY DISEASE - LIPOPROTEIN(A), LDL-CHOLESTEROL AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (1994) (2)
- The ID gene is serum Activated but is not required for De-Differentiation in Vascular Smooth Muscle Cells (1991) (2)
- Magnetic-Resonance Studies of the Molecular Motion of Lipids in Bilayers and Membranes (1973) (1)
- Synthesis of fluorodeoxy analogues of myo-inositol. (1990) (1)
- Primary Confluent Vascular Smooth Muscle Cells (VSMCs) are Inhomogeneous with Respect to Smooth Muscle Specific Myosin Heavy Chain (SM-MHC) Content (1991) (1)
- Organisation and disorder in membranes (1975) (1)
- The role of lipids in the functioning of a membrane protein (1980) (1)
- 1.W08.1 Lp(a) and endothelium: A feedback loop in atherosclerosis (1997) (1)
- First Entry into M Phase Causes a Large Accumulation of Non-Muscle Myosin in Rat Vascular Smooth Muscle Cells (1991) (1)
- Effects of TGF-β on vascular smooth muscle cell growth (1993) (1)
- Expression of mRNA Isoforms of Latent Transforming Growth Factor-β Binding Protein-1 in Coronary Atherosclerosis and Human Tissues (2011) (1)
- Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by increasing the G2 to M phase of the cell cycle (1992) (1)
- How the Structure of the Sarcoplasmic Reticulum Regulates the Accumulation of Calcium (1976) (1)
- and Is Associated with Increased Incidence of Invasive Breast Cancer A Transforming Growth Factor{beta}1 Signal Peptide Variant Increases Secretion in Vitro (2010) (0)
- CALCULATION OF DIPOLAR NUCLEAR MAGNETIC RELAXATION TIMES IN MOLECULES WITH MULTIPLE INTERNAL ROTATIONS PART 2, THEORETICAL RESULTS FOR ANISOTROPIC OVER-ALL MOTION OF THE MOLECULE, AND COMPARISON WITH (13)C RELAXATION TIMES IN N-ALKANE (1974) (0)
- Mitogenic effects of vasoactive peptides on rat vascular smooth muscle cells (1991) (0)
- blood pressure in the HERITAGE Family Study gene-race interactions for resting and exercise (2012) (0)
- Synthesis of Some Deoxyfluoro Analogues of myo-Inositol. (1991) (0)
- Contents Continued (2001) (0)
- Dissociation between Recovery of pHi and Contraction Following Acid Loading in Perfused Heart (1993) (0)
- Composes et therapies destines a la prevention d'affections vasculaires ou non vasculaires (1998) (0)
- 22nd Meeting of the ESM, August 2002 (2001) (0)
- Synthesis and Tritium Radiolabeling of Fluorinated Analogues of myo- Inositol. (1992) (0)
- Lp(a) and TGFb in Atherosclerosis (1999) (0)
- The effects of temperature on the local anaesthetic action of primary alcohols [proceedings]. (1978) (0)
- Fromthe ‡ SectionofCardiovascularBiology,DepartmentofBiochemistry,UniversityofCambridge,DowningSite, Cambridge,CB21QW,UnitedKingdom,the § DivisionofCellandMolecularBiology,SirAlexanderFlemmingBuilding,Imperial College,SouthKensingtonCampus,LondonSW72AZ,UnitedKingdom,theDepartmentofPhysiology,Develop (2008) (0)
- Selective inhibition of the proliferation of human and rat vascular smooth muscle cells by inhibitors of ADPRT (1992) (0)
- The Design and Properties of a Series of Calcium Indicators which Shift from Rhodamine-Like to Fluorescein-Like Fluorescence on Binding Calcium. (2010) (0)
- Ca 2 l transient , Mg 2 + , and pH measurements in the cardiac cycle by 19 F NMR ( " F cation indicators / myoplasmic Ca 2 l buffer / gated NMR spectra ) (0)
- Analysis of Lipid Conformation and Biosynthesis by Nuclear Resonance spectroscopy (1974) (0)
- Na+-H+ Antiport and Na+/HCO3− Co-Influx in Recovery from Intracellular Acidosis in Perfused Heart (1993) (0)
- Calcium, drugs and hormones (1986) (0)
- Prevention and treatment of pathologies associated with abnormal proliferation of smooth muscle cells (1994) (0)
- Metabolic inhibition in primary cell cultures by lipid-soluble molecules. (1970) (0)
- Design and Properties of New 19F NMR Ca2+ Indicators: Modulation of the Affinities of BAPTA Derivatives via Alkylation. (2010) (0)
- Intracellular calcium measurements by 19 F NMR of fluorine-labeled chelators ( calcium indicators / mitogenic stimulation / thymocytes ) (1999) (0)
- Expression of Basic Helix-Loop-Helix Proteins and Smooth Muscle Phenotype in the Adult Rat Aorta (1999) (0)
- Long-chain alcohols (C10-C12) can block nerve impulses [proceedings]. (1978) (0)
- Prevention et traitement de pathologies cardio-vasculaires au moyen d'analogues de tamoxifene (1996) (0)
- Selective Inhibition of the Proliferation of Human and RAT Vascular Smooth Muscle Cells by Inhibitors of Adenosine Diphosphoribosyl Transferase (ADPRT) (1992) (0)
- Activation of the tgfΒ/activin signaling pathway in intimal hyperplasia and atherosclerosis (2010) (0)
- Molecular Mechanisms of Non-Specific Drug Action (1978) (0)
- The binding of benzyl alcohol to erythrocyte membranes. (1970) (0)
- GTP gamma S activation of proto-oncogene expression in transiently permeabilised Swiss 3T3 fibroblasts. (1988) (0)
- Cloning and analysis of the promoter region of the rat SM22x gene (2005) (0)
- Structural comparisons of native and reaggregated membranes. (1971) (0)
- An inhibitor of vascular smooth muscle cells for therapeutic use (1994) (0)
- Prevention et traitement de pathologies associees a la proliferation anormale des cellules des muscles lisses (1994) (0)
- PAI activity and PAI-1 antigen both increase during a fat tolerance test: Associations with PAI-1 genotype and TGF-beta levels (1997) (0)
- Heterogeneity, dedifferentiation and proliferation of primary rat vascular smooth muscle cells and clones (1992) (0)
- GTP gamma S inhibits early c-myc protein accumulation but not DNA synthesis in Swiss 3T3 fibroblasts. (1990) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With James C. Metcalfe?
James C. Metcalfe is affiliated with the following schools:
